5 pharmaceutical equipment companies released performance forecasts: fierce competition is still hot

Early spring and early summer, unconsciously, May has arrived, a number of pharmaceutical equipment listed companies released the first quarter of 2018 performance forecast, including Chutian Technology, Dongfulong, Qianshan Pharmaceutical, Xinlai Yingcai, Canaan Technology Wait. The author will conduct a specific analysis based on the notices issued by these pharmaceutical equipment companies.

Chutian Technology: Main income increased by 37.72% over the same period of last year

In the first quarter of 2018, Chutian Technology's main income was 343,883,596.65 yuan, an increase of 37.72% over the same period of last year; the net profit attributable to shareholders of listed companies was 23,946,508.81 yuan. The year-on-year decline was 6.88%. Regarding the reasons for the change in performance, Chutian Technology stated that during the reporting period, the company complied with the market development and continued to expand and broaden the product chain around the strategic plan, and the new orders in the first quarter of this year increased by 21.52% over the same period of the previous year. In addition, Chutian Technology also increased the intensity of equipment upgrades and actively innovated products. In the first quarter, R&D investment increased by 37.73% compared with the same period of the previous year.

For a long time, Chutian Technology has been at the forefront of intelligent equipment production and R&D, and has actively transformed into a pharmaceutical industry 4.0 smart factory total solution provider. In the development of intelligence and integration, Chutian Technology has more and more advantages, and it is also exerting its own advantages to better guide and match the needs of the pharmaceutical field, thus ensuring the high quality and high safety of the people.

Dongfulong: It is expected that the first quarter results will decline in the same direction

In the first quarter, Dongfulong expected its performance to decline in the same direction. The net profit attributable to shareholders of listed companies decreased by 40% to 60% compared with the same period of the previous year. During the reporting period, Dongfulong deepened its corporate development strategy, focusing on the research of pharmaceutical manufacturing science and medical science manufacturing, practicing the integration and innovation of pharmaceutical equipment and pharmaceutical technology, and strengthening the upstream and downstream linkage of the industry. Due to the fierce market competition, the company's performance has changed due to the increase in the proportion of low-margin products in the current period, the combination of labor costs and rising costs.

The fierce competition and upgrading and transformation have always been the key words of the pharmaceutical equipment industry. In this regard, Dongfulong has done a good job of transformation in light of its actual situation. However, the transition is not an easy task. During the period, the “burning” of funds and the increase in costs will cause fluctuations in performance. It is hoped that at the moment when the concentration of the pharmaceutical equipment industry will increase, Dongfulong will maintain its advantages and play the role of a leading company.

Qianshan Pharmaceutical Machinery: The net profit attributable to shareholders of listed companies is expected to fall by 510%-490% year-on-year.

It is estimated that from January to March 2018, Qianshan Pharmaceuticals' net profit attributable to shareholders of listed companies will be 924.99 million yuan to 879.01 million yuan, a year-on-year decrease of 510%-490%. For the change in performance, Qianshan Pharmaceutical Machinery said that the main reason was that operating income decreased by 69.95% year-on-year, and financial expenses increased significantly year-on-year.

As a leading company in China's pharmaceutical equipment, Qianshan Pharmaceutical has gradually transformed itself from a single pharmaceutical device to pharmaceutical equipment, packaging machinery, medical equipment and pharmaceutical packaging materials for further growth. This year, it is very difficult for Qianshan Pharmaceutical Machinery. It is also hoped that the company will successfully overcome the difficulties and help the healthy development of the industry.

Xinlai Yingcai: The business volume of the three major industries is rising steadily

During the reporting period, the total operating income of Xinlai Yingcai was RMB 166,308,605.23, an increase of 13.02% over the same period of the previous year. The net profit attributable to shareholders of listed companies was 5,676,154.11, compared with the same period of last year. The increase was 79.84%. For the reasons for the increase in performance, Xinlai Yingcai said that during the reporting period, the company actively expanded the business scale of the vacuum semiconductor industry, and more accurately opened up the market to meet the needs of customers in different industries. Xinlai Yingcai has constructed corresponding brands in the three major industries of biomedicine, food and vacuum electronics. The business volume of the three major industries has steadily increased to varying degrees.

As a leading company in clean application materials, Xinlai Yingcai has been committed to the cutting-edge technology in the industry, such as sanitary pump valves and pipe fittings. Based on the pursuit and exploration of core technologies, Xinlai Yingcai is farther and farther in the development of the industry. It can be seen from the performance forecast that the growth of Xinlai Yingcai's performance is still going on, and what kind of excitement will it show us in the future? Wait and see!

Canaan Technology: It is expected that the current performance will decline in the same period

Canaan Technology expects its current performance to decline in the same period, and the net profit attributable to shareholders of listed companies has decreased from the same period of the previous year: -80% to -50%. During the reporting period, Canaan Science and Technology strictly followed the development plan and business objectives formulated at the beginning of the year, improved management and operation of quality platforms, promoted the development of internal and external enterprises, and gradually implemented the “Solid Solution Intelligent Solution Whole Supplier Supplier” and the strategic layout of the big health industry. In addition, the company has also increased the research and development and development of new products and new markets, continuously strengthening the brand effect and building network channels. However, due to fierce market competition, the overall gross profit margin of the industry declined, labor costs and expenses increased significantly, and net profit was expected to decline from the same period last year.

Mr. Fang Zheng, President of Canaan Technology, said: "The strategic positioning of Canaan in 2018 is to become a leading customer expert. We always pay attention to customer experience and feelings, understand customers' needs better than customers, and be more professional. Provide solutions.” We look forward to the future market performance of Canaan Technology.

Conclusion:

The author only selected the performance forecasts of five companies. From the performance of each company, they more or less mentioned the words of competition, research and development, labor costs, etc. This actually reflects the current status of the industry, that is, the frequent medical policy In the context of increasing corporate innovation and rising market demand, industry competition has intensified, and companies are increasingly eager for talent. With the rise of temperature, the competition climax of pharmaceutical equipment companies is about to come, and which companies will stand out? Which companies will be bound by difficulties? Stay tuned!

Wheel Accessories

Wheel Accessories,Wheel Lug Nuts,Truck Wheel Spacers,Chrome Wheel Nuts

Ningbo Yokelink Machinery Co.,Limited , https://www.yokelink.com